NCT00246402|Completed
Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV
Anti-Lipolytic Strategy for HIV Lipodystrophy
Loading search results
Anti-Lipolytic Strategy for HIV Lipodystrophy
Sponsor study identifier
Secondary identifiers
NIH
interventional
30
1 country
1
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
August 2006
Actual (reported)The purpose of this study is to test whether chronic administration of the drug acipimox will improve hyperlipidemia and insulin sensitivity among HIV infected patients experiencing highly active antiretroviral therapy (HAART) associated metabolic disturbances.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2006
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
October 27, 2005
Actual (reported)October 31, 2005
Actual (reported)August 2006
Actual (reported)Fasting Triglyceride Concentration (Initial, after 3 months)
Insulin Sensitivity (Initial, after 3 months)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Hadigan C, Liebau J, Torriani M, Andersen R, Grinspoon S. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia. J Clin Endocrinol Metab. 2006 Nov;91(11):4438-44. doi: 10.1210/jc.2006-1174. Epub 2006 Aug 29.
Colleen M. Hadigan, MD
Massachusetts General Hospital
First Submitted
October 27, 2005
First Posted
October 31, 2005
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
August 2006
Actual (reported)Contact the study team to confirm eligibility.
Last Updated
May 15, 2014
Record last verified: 2007-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: